Restricted growth: hope and fear as a new drug challenges attitudes to achondroplasia

Dwarfism genetic disorder
BioMarin’s vosoritide could become the world’s first treatment to address the underlying cause of achondroplasia, the most common form of dwarfism. Credit: Hailshadow